loading

Alaunos Therapeutics Inc Stock (TCRT) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
0.00%
0.001
0.001 - 0.004 -
Operating Expenses
78.08%
1.743
7.95 8.664 7.986 9.672
Interest Income/Expense
-
- - 1.068 0.853
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
78.08%
1.743
7.95 8.665 7.986 9.671
Operating Income/Loss
78.09%
-1.742
-7.949 -8.664 -7.982 -9.672
Nonoperating Income/Loss
43.40%
0.06
0.106 0.188 -0.791 -0.376
Income/Loss From Continuing Operations Before Tax
0.00%
0.001
0.001 -8.476 0.004 -10.05
Income/Loss From Continuing Operations After Tax
78.55%
-1.682
-7.843 -8.476 -8.773 -10.05
Net Income/Loss
78.55%
-1.682
-7.843 -8.476 -8.773 -10.05
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
107.15%
16.01
-223.85 240.05 239.80 239.68
Diluted Average Shares
107.15%
16.01
-223.85 240.05 239.80 239.68
Basic Earnings Per Share
94.74%
-0.11
-2.09 -0.04 -0.04 -0.04
Diluted Earnings Per Share
94.74%
-0.11
-2.09 -0.04 -0.04 -0.04
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.94
price down icon 1.35%
$75.45
price up icon 0.87%
$43.39
price up icon 3.19%
$378.13
price up icon 0.30%
$206.16
price up icon 7.31%
$120.72
price up icon 1.84%
Cap:     |  Volume (24h):